These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21016167)

  • 41. Coagulation time of the blood in lusteroid tubes; a study of patients receiving dicumarol.
    KADISH AH
    Am Heart J; 1947 Aug; 34(2):225-9. PubMed ID: 20255266
    [No Abstract]   [Full Text] [Related]  

  • 42. Thrombosis and embolism; a preliminary report on the comparative results of femoral vein interruption and dicumarol therapy.
    ALLEN AW
    Bull N Y Acad Med; 1946 Apr; 22():169-84. PubMed ID: 21018944
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment and prevention of hemorrhage during dicumarol therapy, with special reference to the effect of amino acids on clotting].
    SCHWENZER AW
    Geburtshilfe Frauenheilkd; 1951 Dec; 11(12):1089-1102. PubMed ID: 14926896
    [No Abstract]   [Full Text] [Related]  

  • 44. [SOME BASIC PROBLEMS OF ANTICOAGULANT THERAPY].
    RAEK K
    Orv Hetil; 1964 Jul; 105():1345-52. PubMed ID: 14184213
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of dicumarol on certain factors of blood coagulation.
    SHANBERGE JN
    J Lab Clin Med; 1956 Aug; 48(2):218-22. PubMed ID: 13346188
    [No Abstract]   [Full Text] [Related]  

  • 46. Further investigations on getting patients up from bed early and on dicumarol treatment as a prophylactic for post-operative thrombosis.
    BORGSTROM S
    Acta Chir Scand; 1953; 104(6):425-34. PubMed ID: 13079472
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S
    Policlinico Chir; 1956; 63(3):141-59. PubMed ID: 13349502
    [No Abstract]   [Full Text] [Related]  

  • 48. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of coronary artery disease; dicumarol therapy.
    FALK OP
    J Am Med Assoc; 1947 Jun; 134(6):491-6. PubMed ID: 20239037
    [No Abstract]   [Full Text] [Related]  

  • 50. [Supervision of dicoumarin therapy. Study of the different laboratogs tests].
    SOULIER JP; MANDALAKI T
    Presse Med (1893); 1962 Oct; 70():2041-4. PubMed ID: 13978406
    [No Abstract]   [Full Text] [Related]  

  • 51. [Anticoagulants. II. Indirect anticoagulants with prothrombinopenic action; dicumarol derivatives and synthetic anticoagulants].
    DE ROSNAY CD
    J Med Bord; 1956 Jan; 133(1):71-2. PubMed ID: 13286606
    [No Abstract]   [Full Text] [Related]  

  • 52. [DIRECTED THERAPEUTIC HYPOCOAGULABILITY IN THROMBOEMBOLIC DISEASES].
    KONDI V
    Med Interna (Bucur); 1964 Jun; 16():703-8. PubMed ID: 14170453
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recent progress in anticoagulant therapy of thromboembolism].
    KOLLER F
    Med Hyg (Geneve); 1952 Sep; 10(225):339-41. PubMed ID: 13012319
    [No Abstract]   [Full Text] [Related]  

  • 54. Heparin and dicumarol in severe dysmenorrhoea; with special reference to the occurrence of intravasal aggregation of erythrocytes.
    ZILLIACUS H
    Ann Chir Gynaecol Fenn; 1952; 41(3):165-9. PubMed ID: 13008138
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
    HOLYOKE JB; WHEELWRIGHT HJ
    N Engl J Med; 1952 Jan; 246(1):15-7. PubMed ID: 14882481
    [No Abstract]   [Full Text] [Related]  

  • 56. [Dicumarol prophylaxis of postoperative thrombosis; dosage and toxic reactions].
    ROTTGER H
    Zentralbl Gynakol; 1951; 73(17):1404-9. PubMed ID: 14893917
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy of thrombophlebites and pulmonary embolisms since the introduction of anticoagulants such as heparin and dicumarol; 50 cases].
    FAVRE-GILLY MJ; BOREL-MILHET MF; BRUEL M; GARNIER M
    J Med Lyon; 1951 Mar; 32(748):205-19. PubMed ID: 14824772
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of prolonged treatment with heparin and dicoumarin derivatives on blood coagulability in atherosclerosis].
    JANIAKOWA A
    Pol Arch Med Wewn; 1960; 30():984-7. PubMed ID: 13789399
    [No Abstract]   [Full Text] [Related]  

  • 59. [Thrombophlebitis and pulmonary embolism therapy since the discovery of anticoagulants like heparin and dicumarol].
    FAVRE-GILLY MJ; BOREL-MILHET MF; BRUEL M; GARNIER MM
    J Med Lyon; 1951 Mar; 32(749):277-90. PubMed ID: 14824781
    [No Abstract]   [Full Text] [Related]  

  • 60. Dicumarol therapy in acute coronary thombosis; results in fifty attacks; with review of data on embolic complications and immediate mortality in myocardial infarction.
    NICHOL ES; PAGE SW
    J Fla Med Assoc (1914); 1946 Jan; 32():365-70. PubMed ID: 21007277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.